• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定卵巢透明细胞癌基因特征,反映内在疾病生物学和致癌过程。

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.

机构信息

Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.

出版信息

Oncogene. 2010 Mar 25;29(12):1741-52. doi: 10.1038/onc.2009.470. Epub 2010 Jan 11.

DOI:10.1038/onc.2009.470
PMID:20062075
Abstract

Ovarian clear cell carcinoma (OCCC) shows unique clinical features including an association with endometriosis and poor prognosis. We previously reported that the contents of endometriotic cysts, especially high concentrations of free iron, are a possible cause of OCCC carcinogenesis through iron-induced persistent oxidative stress. In this study, we conducted gene expression microarray analysis using 38 ovarian cancer cell lines and identified genes commonly expressed in both OCCC cell lines and clinical samples, which comprise an OCCC gene signature. The OCCC signature reproducibly predicts OCCC specimens in other microarray data sets, suggesting that this gene profile reflects the inherent biological characteristics of OCCC. The OCCC signature contains known markers of OCCC, such as hepatocyte nuclear factor-1beta (HNF-1beta) and versican (VCAN), and other genes that reflect oxidative stress. Expression of OCCC signature genes was induced by treatment of immortalized ovarian surface epithelial cells with the contents of endometriotic cysts, indicating that the OCCC signature is largely dependent on the tumor microenvironment. Induction of OCCC signature genes is at least in part epigenetically regulated, as we found hypomethylation of HNF-1beta and VCAN in OCCC cell lines. This genome-wide study indicates that the tumor microenvironment induces specific gene expression profiles that contribute to the development of distinct cancer subtypes.

摘要

卵巢透明细胞癌(OCCC)具有独特的临床特征,包括与子宫内膜异位症的关联和不良预后。我们之前报道过,子宫内膜异位症囊肿的内容物,特别是游离铁的高浓度,可能通过铁诱导的持续氧化应激导致 OCCC 癌变。在这项研究中,我们使用 38 种卵巢癌细胞系进行了基因表达微阵列分析,鉴定出在 OCCC 细胞系和临床样本中共同表达的基因,这些基因构成了 OCCC 基因特征。OCCC 特征可在其他微阵列数据集的 OCCC 标本中重现预测,表明该基因谱反映了 OCCC 的固有生物学特征。OCCC 特征包含 OCCC 的已知标志物,如肝细胞核因子-1β(HNF-1β)和 versican(VCAN),以及反映氧化应激的其他基因。用子宫内膜异位症囊肿的内容物处理永生化卵巢表面上皮细胞可诱导 OCCC 特征基因的表达,表明 OCCC 特征在很大程度上依赖于肿瘤微环境。OCCC 特征基因的诱导至少部分是通过表观遗传调控的,因为我们在 OCCC 细胞系中发现 HNF-1β 和 VCAN 的低甲基化。这项全基因组研究表明,肿瘤微环境诱导特定的基因表达谱,有助于不同癌症亚型的发展。

相似文献

1
Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.鉴定卵巢透明细胞癌基因特征,反映内在疾病生物学和致癌过程。
Oncogene. 2010 Mar 25;29(12):1741-52. doi: 10.1038/onc.2009.470. Epub 2010 Jan 11.
2
Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.肝细胞核因子-1β(HNF-1β)促进卵巢透明细胞癌中的葡萄糖摄取和糖酵解活性。
Mol Carcinog. 2015 Jan;54(1):35-49. doi: 10.1002/mc.22072. Epub 2013 Sep 17.
3
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.卵巢癌中的基因表达反映了形态学和生物学行为,可将透明细胞癌与其他预后不良的卵巢癌区分开来。
Cancer Res. 2002 Aug 15;62(16):4722-9.
4
Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.骨桥蛋白在卵巢透明细胞癌中的过表达:与肝细胞核因子-1β表达密切相关。
Histopathology. 2008 May;52(6):682-8. doi: 10.1111/j.1365-2559.2008.03006.x. Epub 2008 Apr 2.
5
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).卵巢子宫内膜异位症相关透明细胞癌的分子发病机制(综述)
Oncol Rep. 2009 Aug;22(2):233-40.
6
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.利用基因表达阵列和递归下降分割分析筛选上皮性卵巢癌的潜在标志物。
Clin Cancer Res. 2004 May 15;10(10):3291-300. doi: 10.1158/1078-0432.CCR-03-0409.
7
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.印记肿瘤抑制基因ARHI和PEG3在人类卵巢癌中因杂合性缺失和启动子甲基化而最常下调。
Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.
8
Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma.卵巢透明细胞癌中 ARID1A 缺乏与全基因组 DNA 甲基化的关系。
J Transl Med. 2024 Jun 10;22(1):556. doi: 10.1186/s12967-024-05311-7.
9
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.卵巢癌和子宫内膜癌的浆液性、子宫内膜样和透明细胞亚型的基因表达谱。
Clin Cancer Res. 2005 Sep 15;11(18):6422-30. doi: 10.1158/1078-0432.CCR-05-0508.
10
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.上皮性卵巢癌不同组织学类型中的基因表达模式与正常输卵管、子宫内膜和结肠中的基因表达模式相关。
Clin Cancer Res. 2005 Sep 1;11(17):6116-26. doi: 10.1158/1078-0432.CCR-04-2509.

引用本文的文献

1
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.透明细胞卵巢癌类器官的高通量药物筛选揭示了对蛋白酶体抑制剂和地西他滨的敏感性,并确定AGR2为治疗靶点。
Cancer Res Commun. 2025 Jun 1;5(6):1018-1033. doi: 10.1158/2767-9764.CRC-25-0024.
2
Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma.综合多组学分析揭示肝细胞核因子-1β在结肠腺癌肿瘤免疫微环境、免疫治疗及预后预测中的临床意义。
Cancer Immunol Immunother. 2024 Dec 30;74(1):38. doi: 10.1007/s00262-024-03870-8.
3
Gene signatures for cancer research: A 25-year retrospective and future avenues.
癌症研究的基因特征: 25 年的回顾与未来方向。
PLoS Comput Biol. 2024 Oct 16;20(10):e1012512. doi: 10.1371/journal.pcbi.1012512. eCollection 2024 Oct.
4
Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study.通过多组学分析对卵巢高级别浆液性/子宫内膜样癌进行分子分类:JGOG3025-TR2 研究。
Br J Cancer. 2024 Nov;131(8):1340-1349. doi: 10.1038/s41416-024-02837-x. Epub 2024 Aug 30.
5
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.整合基因组/表观基因组分析将透明细胞卵巢癌的亚型分层,突出了它们的细胞起源。
Sci Rep. 2024 Aug 13;14(1):18797. doi: 10.1038/s41598-024-69796-4.
6
Status and development of research on clear cell carcinoma of the ovary-a visualization-based bibliometric analysis.卵巢透明细胞癌的研究现状与进展——基于可视化的文献计量分析
Transl Cancer Res. 2024 Jun 30;13(6):2950-2970. doi: 10.21037/tcr-23-2351. Epub 2024 Jun 27.
7
Clinical significance of initial symptoms in endometriosis-associated ovarian cancer.子宫内膜异位症相关卵巢癌初始症状的临床意义
Turk J Obstet Gynecol. 2024 Mar 4;21(1):28-36. doi: 10.4274/tjod.galenos.2024.59019.
8
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.伴有子宫内膜异位症的卵巢透明细胞癌的转录组分析。
Front Endocrinol (Lausanne). 2023 Aug 9;14:1162786. doi: 10.3389/fendo.2023.1162786. eCollection 2023.
9
CD8 + T cell infiltration is associated with improved survival and negatively correlates with hypoxia in clear cell ovarian cancer.CD8+T 细胞浸润与改善的生存相关,与透明细胞卵巢癌中的缺氧呈负相关。
Sci Rep. 2023 Apr 21;13(1):6530. doi: 10.1038/s41598-023-30655-3.
10
Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.单机构队列中起源于有或无子宫内膜异位症的卵巢透明细胞癌。
Discov Oncol. 2023 Apr 1;14(1):39. doi: 10.1007/s12672-023-00649-8.